Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

NRX Pharmaceuticals (NRXP) EPS (Basic) (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed EPS (Basic) for 2 consecutive years, with $0.2 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 125.97% to $0.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.45 through Dec 2025, up 39.74% year-over-year, with the annual reading at -$1.34 for FY2025, 43.22% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.2 at NRX Pharmaceuticals, up from -$0.27 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.2 in Q4 2025, with the low at -$0.98 in Q2 2025.